Medprin Regenerative Medical Technologies Co., Ltd. () Stock Analysis

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

The company has declared Positive results for the last 6 consecutive quarters

OPERATING CASH FLOW(Y) Highest at CNY 129.71 MM
INTEREST COVERAGE RATIO(Q) The company hardly has any interest cost
NET PROFIT(9M) At CNY 70.95 MM has Grown at 61.31%

With ROE of 13.12%, it has a expensive valuation with a 1.51 Price to Book Value

Market Beating Performance

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CNY 1,079 Million (Small Cap)

P/E

11.00

Industry P/E

Dividend Yield

0.83%

Debt Equity

-0.32

Return on Equity

13.12%

Price to Book

1.51

Revenue and Profits:

Net Sales:

82 Million

(Quarterly Results - Jun 2025)

Net Profit:

23 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

44.09%

6 Months

44.37%

1 Year

71.5%

2 Years

54.99%

3 Years

88.41%

4 Years

0.0%

5 Years

0.0%

Medprin Regenerative Medical Technologies Co., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

19.81%

EBIT Growth (5y)

56.35%

EBIT to Interest (avg)

35.56

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.26

Sales to Capital Employed (avg)

0.36

Tax Ratio

14.29%

Dividend Payout Ratio

50.34%

Pledged Shares

Institutional Holding

ROCE (avg)

9.56%

ROE (avg)

8.17%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.51

EV to EBIT

9.19

EV to EBITDA

7.03

EV to Capital Employed

1.74

EV to Sales

2.76

PEG Ratio

0.22

Dividend Yield

0.83%

ROCE (Latest)

18.96%

ROE (Latest)

13.12%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 29.36% vs 58.46% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 32.76% vs 324.39% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "82.40",
          "val2": "63.70",
          "chgp": "29.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "31.50",
          "val2": "23.00",
          "chgp": "36.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.40",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.10",
          "val2": "-0.30",
          "chgp": "133.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "23.10",
          "val2": "17.40",
          "chgp": "32.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "294.50%",
          "val2": "252.80%",
          "chgp": "4.17%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 20.72% vs 17.13% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 92.91% vs 14.57% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "273.20",
          "val2": "226.30",
          "chgp": "20.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "102.50",
          "val2": "68.60",
          "chgp": "49.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.20",
          "val2": "2.40",
          "chgp": "-50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.30",
          "val2": "0.10",
          "chgp": "-400.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "78.90",
          "val2": "40.90",
          "chgp": "92.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "273.00%",
          "val2": "185.70%",
          "chgp": "8.73%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

82.40

63.70

29.36%

Operating Profit (PBDIT) excl Other Income

31.50

23.00

36.96%

Interest

0.00

0.40

-100.00%

Exceptional Items

0.10

-0.30

133.33%

Consolidate Net Profit

23.10

17.40

32.76%

Operating Profit Margin (Excl OI)

294.50%

252.80%

4.17%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 29.36% vs 58.46% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 32.76% vs 324.39% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

273.20

226.30

20.72%

Operating Profit (PBDIT) excl Other Income

102.50

68.60

49.42%

Interest

1.20

2.40

-50.00%

Exceptional Items

-0.30

0.10

-400.00%

Consolidate Net Profit

78.90

40.90

92.91%

Operating Profit Margin (Excl OI)

273.00%

185.70%

8.73%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 20.72% vs 17.13% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 92.91% vs 14.57% in Dec 2023

All Annual Results

Company CV

About Medprin Regenerative Medical Technologies Co., Ltd.

Medprin Regenerative Medical Technologies Co., Ltd.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available